An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...

FirstHealth is inviting the community to take flight with them on Nov. 8 for the inaugural Wings of Hope Walk & Run. Taking ...

Deep learning model outperformed clinical tools, cutting false positives and enhancing accuracy in CT lung cancer screening ...

bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment bioAffinity Technologies, Inc.

An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.

CONTEXT: The above video originally aired on September 14th TOPEKA (KSNT) – The University of Kansas Health System St.

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules ...

Incidental pulmonary nodules are a common finding on chest imaging, but one program is taking an uncommon approach to managing them. Incidental nodules present a growing diagnostic and management ...

Pulmonologist at Apollo Hospitals Bilaspur, highlights how systemic gaps in diagnosis and access to testing are causing lung cancer to be mislabelled as tuberculosis, delaying life-saving treatment ...

The FANSS shows a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history, which is comparable to ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.